Canterbury Tower Case Study
- Authors
- RB Health Partners, Inc.
- Facility
- Canterbury Tower Retirement Community
- Download
- Full Report
Overview
Canterbury Tower, a 60-bed continuing care retirement community, implemented Protect 900 units in the hallways, dining room, and activity area in October 2015. In February 2016, they began implementing bedside Protect 200 units for each new admission, readmission, and any residents identified with any type of infection. This study compares the total number of respiratory nosocomial infections and infection rates before and after each implementation of the Novaerus technology.
A 35-month review was conducted to evaluate the results of implementation.
Methodology
A Nurse Risk Manager Consultant with RB Health Partners, Inc. visited the facility for two days to abstract information and review the data. The periods selected for initial pre- and post-review were October 2013 through September 2014 and October 2014 through September 2015. Comparison of like periods reduces the risk of skewed data related to seasonal variances.
The implementation of individual Novaerus units in targeted rooms began in February 2016. A period of seven months, February through August of 2014, 2015, and 2016, was selected to provide equivalent seasonal timeframes for comparison in each of the different configurations of the Novaerus technology.
Results
In the 12-month period after the initial implementation of the Protect 900 units in shared areas, the total number of nosocomial respiratory infections at Canterbury Tower decreased from 31 in 2014 to 24 in 2015, a 22.58% reduction.
In the 7-month period after implementation of the individual Protect 200 (Nano) units in targeted patient rooms in February 2016, the total number of nosocomial respiratory infections decreased from 15 in 2014 to 1 in 2016, a 93.33% reduction.